A growing number of studies have shown that Tim3 up-regulation in tumor tissue is associated with poor prognosis in a wide variety of cancers such as CRC, gastric cancer, prostate cancer, clear cell renal cancer, urothelial bladder cancer, and cervical cancer (29–34). Here, HAVCR2 is linked to cancer.